ENMD-1198
CAS: 864668-87-1
Ref. 3D-PJB66887
1mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire |
Product Information
ENMD-1198 is a novel analog of the naturally occurring molecule endostatin. It has been shown to inhibit endothelial cell proliferation in vitro, but it is not yet known whether this effect will translate to clinical efficacy. ENMD-1198 is currently undergoing phase I and II clinical trials for the treatment of breast cancer, prostate cancer, and other cancers. The drug has been shown to be well tolerated at doses up to 10 mg/kg, with no significant adverse reactions reported.
Chemical properties
Technical inquiry about: 3D-PJB66887 ENMD-1198
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.